The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Open accessAbstract
BACKGROUND: The extent to which diabetes mellitus or hyperglycemia is related to risk of death from cancer or other nonvascular conditions is uncertain. METHODS: We calculated hazard ratios for cause-specific death, according to baseline diabetes status or fasting glucose level, from individual-participant data on 123,205 deaths among 820,900 people in 97 prospective studies. RESULTS: After adjustment for age, sex, smoking status, and body-mass index, hazard ratios among persons with diabetes as compared with persons without diabetes were as follows: 1.80 (95% confidence interval [CI], 1.71 to 1.90) for death from any cause, 1.25 (95% CI, 1.19 to 1.31) for death from cancer, 2.32 (95% CI, 2.11 to 2.56) for death from vascular causes, and 1.73 (95% CI, 1.62 to 1.85) for death from other causes. Diabetes (vs. no diabetes) was moderately associated with death from cancers of the liver, pancreas, ovary, colorectum, lung, bladder, and breast. Aside from cancer and vascular disease, diabetes (vs. no diabetes) was also associated with death from renal disease, liver disease, pneumonia and other infectious diseases, mental disorders, nonhepatic digestive diseases, external causes, intentional self-harm, nervous-system disorders, and chronic obstructive pulmonary disease. Hazard ratios were appreciably reduced after further adjustment for glycemia measures, but not after adjustment for systolic blood pressure, lipid levels, inflammation or renal markers. Fasting glucose levels exceeding 100 mg per deciliter (5.6 mmol per liter), but not levels of 70 to 100 mg per deciliter (3.9 to 5.6 mmol per liter), were associated with death. A 50-year-old with diabetes died, on average, 6 years earlier than a counterpart without diabetes, with about 40% of the difference in survival attributable to excess nonvascular deaths. CONCLUSIONS: In addition to vascular disease, diabetes is associated with substantial premature death from several cancers, infectious diseases, external causes, intentional self-harm, and degenerative disorders, independent of several major risk factors. (Funded by the British Heart Foundation and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prediabetes is linked with increased risks of major manifestations of vascular disease, but it remains unclear whether the elevated disease risks depend on development of clinical diabetes.84,85”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [85]
In the citing paper
“A recent individual-level evidence from prospective studies suggests that fasting hyperglycaemia (figure 3), postload glucose, and A1c are all robust predictors of vascular mortality86,88,89 and, according to multivariable adjusted analyses, these associations are independent of vascular risk factors, such as obesity, blood pressure, triglyceride and lipoproteins.84,85,87”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [85]
In the citing paper
“The study found that a 50-year-old with T2DM died, on average, 6 years earlier than an individual without T2DM, with about 40% of the difference in survival attributable to excess non-vascular deaths.95”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [95]
In the citing paper
“Aside from CV death, results from the Emerging Risk Factors Collaboration, including 820 900 people, demonstrate that T2DM is independently associated with increased risk of death from several cancers (i.e.liver, pancreas, ovary, colorectum, lung, bladder, and breast), renal and liver disease, pneumonia and other infectious diseases, mental and nervous system disorders, non-hepatic digestive dis”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [95]
In the citing paper
“These are consistent with downward secular trends in cardiovascular disease and improvements in mortality and are in line with previously reported estimates of the reduction in life expectancy due to diabetes [23].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Self-citationMortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,010
Aune, D., Schlesinger, S., Norat, T., & Ríboli, E. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.09.009 · Cited by 52
Cholesterol-Lowering Agents: Statins—For Everyone?
Hadjiphilippou, S., & Ray, K. K. (2019) · Circulation Research · doi:10.1161/circresaha.118.313245 · Cited by 49
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Schinner, S. (2011) · Yearbook of Endocrinology · doi:10.1016/j.yend.2011.06.029 · Cited by 52
Diabetes mellitus as a comorbidity in COVID-19 infection in the United Arab Emirates
Elemam, N. M., Hannawi, H., Salmi, I. A., Naeem, K., Alokaily, F., & Hannawi, S. (2021) · Saudi Medical Journal · doi:10.15537/smj.2021.2.25700 · Cited by 50
Gunasekar, S. K., Xie, L., Kumar, A., Hong, J., Chheda, P. R., Chen, K., Kern, D. M., My-Ta, C., Maurer, J. M., Heebink, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28435-0 · Cited by 51
The growing range of complications of diabetes mellitus
Hamblin, P. S., Russell, A. W., Talic, S., & Zoungas, S. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.12.006 · Cited by 52
Long‐term coeliac disease influences risk of death in patients with type 1 diabetes
Mollazadegan, K., Sanders, D. S., Ludvigsson, J. F., & Ludvigsson, J. F. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12092 · Cited by 52
Diabetes mellitus increases the risk of early gastric cancer development
Sekikawa, A. M., Fukui, H., Maruo, T., Tsumura, T., Okabe, Y., & Osaki, Y. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.05.020 · Cited by 51
Cardiovascular Implications of Hypoglycemia in Diabetes Mellitus
Connelly, K. A., Yan, A. T.-K., Leiter, L. A., Bhatt, D. L., & Verma, S. (2015) · Circulation · doi:10.1161/circulationaha.115.015946 · Cited by 50
Ragot, S., Saulnier, P., Velho, G., Gand, E., de Hauteclocque, A., Slaoui, Y., Potier, L., Sosner, P., Halimi, J., Zaoui, P., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2607 · Cited by 51
Mor, A., Berencsi, K., Nielsen, J. S., Rungby, J., Friborg, S. G., Brandslund, I., Christiansen, J. S., Vaag, A. A., Beck‐Nielsen, H., Sørensen, H. T., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw345 · Cited by 54
Sciacca, L., Moli, R. L., & Vigneri, R. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00021 · Cited by 52
Xu, C., & Cao, Z. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03439-y · Cited by 55
Zhang, N., Wang, Y., Li, W., Wang, Y., Zhang, H., Xu, D., Chen, R., Tang, L., & Tang, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-90785-8 · Cited by 53
Arnaboldi, L., & Corsini, A. (2015) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(14)70002-9 · Cited by 51
Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland
Jackson, C., Jones, N. R. V., Walker, J. J., Fischbacher, C., Colhoun, H. M., Leese, G., Lindsay, R. S., McKnight, J. A., Morris, A. D., Petrie, J. R., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2667-1 · Cited by 50
Breeze, P. R., Thomas, C., Squires, H., Brennan, A., Greaves, C. J., Diggle, P. J., Brunner, E. J., Tabák, Á. G., Preston, L., & Chilcott, J. B. (2017) · Diabetic Medicine · doi:10.1111/dme.13314 · Cited by 51
Categories of glucose tolerance and continuous glycemic measures and mortality
Kowall, B., Rathmann, W., Heier, M., Giani, G., Peters, A., Thorand, B., Huth, C., Icks, A., & Meisinger, C. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9609-y · Cited by 47
Diabetes and the Female Disadvantage
Woodward, M., Peters, S. A. E., & Huxley, R. (2015) · Women s Health · doi:10.2217/whe.15.67 · Cited by 51
Amor, A. J., Catalán, M., Pérez, A., Herreras, Z., Pinyol, M., Sala‐Vila, A., Cofán, M., Gilabert, R., Ros, E., & Ortega, E. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.014 · Cited by 50
Barakat, A., Islam, M. S., Al‐Majid, A. M., Ghabbour, H. A., Sammer Yousuf, B., Ashraf, M., Shaikh, N. N., Choudhary, M. I., Khalil, R., & Ul‐Haq, Z. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.07.009 · Cited by 50
Xu, D., Fang, H., Xu, W., Yan, Y., Liu, Y., & Yao, B. (2016) · Scientific Reports · doi:10.1038/srep39633 · Cited by 50
Houge, I. S., Hoff, M., Thomas, R., & Videm, V. (2020) · Scientific Reports · doi:10.1038/s41598-020-60621-2 · Cited by 52
Lipid and metabolic syndrome traits in coronary artery disease: a Mendelian randomization study
Thomas, D. G., Wei, Y., & Tall, A. R. (2020) · Journal of Lipid Research · doi:10.1194/jlr.p120001000 · Cited by 53
State of Evidence on Oral Health Problems in Diabetic Patients: A Critical Review of the Literature
González‐Moles, M. Á., & Ramos‐García, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225383 · Cited by 75
Green synthesized gold nanoparticles and CuO-based nonenzymatic sensor for saliva glucose monitoring
Ali, M. Y., Abdulrahman, H. B., Ting, W., & Howlader, M. M. R. (2024) · RSC Advances · doi:10.1039/d3ra05644a · Cited by 49
Kowall, B., Rathmann, W., & Kostev, K. (2014) · Diabetes Care · doi:10.2337/dc14-0977 · Cited by 49
Yang, X., Ma, R. C. W., So, W. Y., Kong, A. P. S., Xu, G., & Chan, J. C. N. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01551.x · Cited by 49
Early postural blood pressure response and cause-specific mortality among middle-aged adults
Fedorowski, A., Hedblad, B., & Melander, O. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9578-1 · Cited by 48
Liu, Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i27.9090 · Cited by 51
Yu, B., HEISS, G. M., Alexander, D. C., Grams, M. E., & Boerwinkle, E. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv213 · Cited by 46
Mor, A., Petersen, I., Sørensen, H. T., & Thomsen, R. W. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011523 · Cited by 49
Bonora, B. M., Cappellari, R., Albiero, M., Avogaro, A., & Fadini, G. P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00824 · Cited by 48
Barbhaiya, M., Feldman, C. H., Chen, S. K., Guan, H., Fischer, M. A., Everett, B. M., & Costenbader, K. H. (2020) · Arthritis Care & Research · doi:10.1002/acr.24328 · Cited by 49
Ballin, M., Nordström, P., Niklasson, J., Alamäki, A., Condell, J., Tedesco, S., & Nordström, A. (2020) · BMC Public Health · doi:10.1186/s12889-020-09929-2 · Cited by 47
Sandoval, E., McLachlan, S., Price, A. H., MacGillivray, T., Strachan, M. W. J., Wilson, J. F., & Price, J. F. (2021) · Diabetologia · doi:10.1007/s00125-021-05499-z · Cited by 48
Wang, B., Fu, Y., Tan, X. W., Wang, N., Qi, L., & Lu, Y. (2024) · BMC Medicine · doi:10.1186/s12916-024-03343-w · Cited by 59
Associations between Diabetes Mellitus and Selected Cancers
Pliszka, M., & Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137476 · Cited by 53
Ueyama, M., Nishida, N., Korenaga, M., Korenaga, K., Kumagai, E., Yanai, H., Adachi, H., Katsuyama, H., Moriyama, S., Hamasaki, H., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1116-6 · Cited by 48
Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction?
Bianchi, C., Miccoli, R., & Prato, S. D. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0371-2 · Cited by 47
Chiu, C.-C., Huang, C., Chen, Y., Chen, T., Liang, Y. J., Lin, S., Chen, J., Leu, H., & Chan, W. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.8276 · Cited by 48
Diabetes and Lung Cancer Among Postmenopausal Women
Luo, J., Chlebowski, R. T., Wactawski‐Wende, J., Schlecht, N. F., Tinker, L. F., & Margolis, K. L. (2012) · Diabetes Care · doi:10.2337/dc11-2108 · Cited by 48
Cohort Profile: The Helsinki Businessmen Study (HBS)
Strandberg, T. E., Salomaa, V. V., Strandberg, A. Y., Vanhanen, H. T., Sarna, S. J., Pitkälä, K. H., Rantanen, K. K., Savela, S., Pienimäki, T., Huohvanainen, E. A., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv310 · Cited by 48
Cefalu, W. T. (2016) · Diabetes Care · doi:10.2337/dc16-1143 · Cited by 50
Duncan, B. B., Schmidt, M. I., Cousin, E., Moradi‐Lakeh, M., Passos, V. M. D. A., França, E. B., Marinho, F., & Mokdad, A. H. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0216-2 · Cited by 54
Duncan, B. B., França, E. B., Passos, V. M. D. A., Cousin, E., Ishitani, L. H., Malta, D. C., Naghavi, M., Mooney, M., & Schmidt, M. I. (2017) · Revista Brasileira de Epidemiologia · doi:10.1590/1980-5497201700050008 · Cited by 48
Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan
for the LUCID study investigators, Tateishi, R., Matsumura, T., Okanoue, T., Shima, T., Uchino, K., Fujiwara, N., Senokuchi, T., Kon, K., Sasako, T., et al. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-020-01754-z · Cited by 48
Misra, S., Holman, N., Barron, E., Knighton, P., Warner, J., Kar, P. S., Young, B., & Valabhji, J. (2022) · Diabetic Medicine · doi:10.1111/dme.14940 · Cited by 50
Blood glucose concentrations and breast cancer risk in women without diabetes: a meta-analysis
Boyle, P., Koechlin, A., Pizot, C., Boniol, M., Robertson, C., Mullie, P., Bolli, G. B., Rosenstock, J., & Autier, P. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0460-z · Cited by 47
Laugesen, E., Rossen, N. B., Peters, C. D., Mæng, M., Ebbehøj, E., Knudsen, S. T., Hansen, K. W., Bøtker, H. E., & Poulsen, P. L. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt195 · Cited by 49
The “Rule of Halves” Does Not Apply in Peru
Lerner, A. G., Bernabé‐Ortiz, A., Gilman, R. H., Smeeth, L. L., & Miranda, J. J. (2013) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0b013e318285ef60 · Cited by 47
Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer
Forte, V. A., Pandey, A. K., Abdelmessih, R. M., Forte, G., Whaley‐Connell, A. T., Sowers, J. R., & McFarlane, S. I. (2012) · Cardiorenal Medicine · doi:10.1159/000337314 · Cited by 50
Lonn, E., Bosch, J., Díaz, R., López-Jaramillo, P. A., Ramachandran, A., Hâncu, N., Hanefeld, M., Krum, H., Rydén, L., Smith, S. L., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2129 · Cited by 48
Bechini, A., Ninci, A., Riccio, M. D., Biondi, I., Bianchi, J., Bonanni, P., Mannucci, E., & Monami, M. (2020) · Vaccines · doi:10.3390/vaccines8020263 · Cited by 48
Coronavirus disease 2019 (COVID‐19) update: From metabolic reprogramming to immunometabolism
Rudiansyah, M., Jasim, S. A., pour, Z. G. M., Athar, S. S., Jeda, A. S., Doewes, R. I., Jalil, A. T., Bokov, D. O., Mustafa, Y. F., Noroozbeygi, M., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27929 · Cited by 47
DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits
Razavi, M. A., Wei, Y., Rao, X., & Zhong, J. (2022) · Military Medical Research · doi:10.1186/s40779-022-00410-2 · Cited by 50
Arroyave, F., Montaño, D., & Lizcano, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228685 · Cited by 52
Lv, Q., Li, Z., Sui, A., Yang, X., Han, Y., & Yao, R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.977187 · Cited by 48
Habib, S. L., & Liang, S. (2014) · Oncotarget · doi:10.18632/oncotarget.1833 · Cited by 46
Furukawa, S., Saito, I., Yamamoto, S., Miyake, T., Ueda, T., Niiya, T., Torisu, M., Kumagi, T., Sakai, T., Minami, H., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0086 · Cited by 47
Projection of prediabetes and diabetes population size in Singapore using a dynamic Markov model
Wong, L. Y., Toh, M. P. H. S., & Tham, L. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12384 · Cited by 46
Giorda, C. B., Carnà, P., Salomone, M., Picariello, R., Costa, G., Tartaglino, B., & Gnavi, R. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1142-y · Cited by 46
Aryan, Z., Ghajar, A., Faghihi‐Kashani, S., Afarideh, M., Nakhjavani, M., & Esteghamati, A. (2018) · Annals of Nutrition and Metabolism · doi:10.1159/000488537 · Cited by 51
Hackett, R. A., Moore, C., Steptoe, A., & Lassale, C. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-35238-1 · Cited by 48
Metabolic Effects of Bile Acids: Potential Role in Bariatric Surgery
Flynn, C. R., Albaugh, V. L., & Abumrad, N. N. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.04.014 · Cited by 48
Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes
Shieh, S., Probst, J. C., Sung, F.-C., Tsai, W., Li, Y.-S., & Chen, C. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-174 · Cited by 46
Effect of Diabetes on Morbidity and Mortality in Patients With Acromegaly
Espósito, D., Olsson, D. S., Franzén, S., Miftaraj, M., Nåtman, J., Guðbjörnsdóttir, S., & Johannsson, G. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac400 · Cited by 46
Advances in Nanomedicine for Precision Insulin Delivery
Caturano, A., Nilo, R., Nilo, D., Russo, V., Santonastaso, E., Galiero, R., Rinaldi, L., Monda, M., Sardu, C., Marfella, R., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17070945 · Cited by 51
Implications of Rising Prediabetes Prevalence
Abraham, T. M., & Fox, C. S. (2013) · Diabetes Care · doi:10.2337/dc13-0792 · Cited by 45
Uehara, A., Kurotani, K., Kochi, T., Kuwahara, K., Eguchi, M., Imai, T., Nishihara, A., Tomita, K., Yamamoto, M., Kuroda, R., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.07.013 · Cited by 47
Kumar, P., Swain, M. M., & Pal, A. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.02.006 · Cited by 45
Circulating calcium levels and the risk of type 2 diabetes: a systematic review and meta-analysis
Zhu, J., Xun, P., Bae, J., Kim, J. H., Kim, D. J., Yang, K., & He, K. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519001430 · Cited by 45
Lim, S. K., Oh, T. J., Dawson, J., & Sattar, N. A. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13850 · Cited by 48
Association between diabetes and haematological malignancies: a population-based study
Gong, I. Y., Cheung, M. C., Read, S. H., Na, Y., Lega, I. C., & Lipscombe, L. L. (2021) · Diabetologia · doi:10.1007/s00125-020-05338-7 · Cited by 45
Yamamoto, L., Yamashita, S.-I., Nomiyama, T., Kawanami, T., Hamaguchi, Y., Shigeoka, T., Horikawa, T., Tanaka, Y., Yanase, T., Kawanami, D., et al. (2021) · Diabetology International · doi:10.1007/s13340-021-00494-6 · Cited by 45
Ting, R. Z. W., Lau, E. S. H., Ozaki, R., Lau, W. W. Y., Kong, A. P. S., Luk, A. O. Y., Chow, C., Ronald, C. W., Wing, Y. K., Chan, J. C. N., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.01.012 · Cited by 45
Prevalence of diabetes mellitus in 2019 novel coronavirus: A meta-analysis
Wang, X., Wang, S., Sun, L., & Qin, G. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108200 · Cited by 44
Hengist, A., Davies, R. G., Walhin, J., Buniam, J., Merrell, L. H., Rogers, L. M., Bradshaw, L., Moreno‐Cabañas, A., Rogers, P. J., Brunstrom, J. M., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101667 · Cited by 53
Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth
Tsutsumi, Y., Nomiyama, T., Kawanami, T., Hamaguchi, Y., Terawaki, Y., Tanaka, T., Murase, K., Motonaga, R., Tanabe, M., & Yanase, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139709 · Cited by 47
DNA aptamer raised against advanced glycation end products inhibits melanoma growth in nude mice
Ojima, A., Matsui, T., Maeda, S., Takeuchi, M., Inoue, H., Higashimoto, Y., & Yamagishi, S. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.5 · Cited by 44
Gordon-Dseagu, V., Shelton, N., & Mindell, J. (2014) · Journal of diabetes and its complications · doi:10.1016/j.jdiacomp.2014.06.016 · Cited by 45
The Asian diabetes phenotypes: Challenges and opportunities
Chan, J. C. N., Yeung, R. O., & Luk, A. O. Y. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.05.011 · Cited by 43
Influence of diabetes mellitus on mortality in breast cancer patients
Zhou, Y., Zhang, X., Gu, C., & Xia, J. (2014) · ANZ Journal of Surgery · doi:10.1111/ans.12877 · Cited by 47
Davis, W. A., Zilkens, R., STARKSTEIN, S. E., Davis, T. M. E., & Bruce, D. G. (2016) · Diabetologia · doi:10.1007/s00125-016-4127-9 · Cited by 45
Fangel, M. V., Nielsen, P. B., Kristensen, J. K., Larsen, T. B., Overvad, T. F., Lip, G. Y. H., & Jensen, M. B. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.10.042 · Cited by 44
Islam, Z., Akter, S., Inoue, Y., Hu, H., Kuwahara, K., Nakagawa, T., Honda, T., Yamamoto, S., Okazaki, H., Miyamoto, T., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1213 · Cited by 44
Effect of eugenol treatment in hyperglycemic murine models: A meta-analysis
Carvalho, R. P. R., Lima, G. D. D. A., & Machado‐Neves, M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105315 · Cited by 52
Vedanthan, R., Kamano, J. H., Chrysanthopoulou, S. A., Mugo, R., Andama, B., Bloomfield, G. S., Chesoli, C., DeLong, A. K., Edelman, D. E., Finkelstein, E. A., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.03.002 · Cited by 44
Chen, D., Wang, M., Shang, X. C., Liu, X., Liu, X., Ge, T., Ren, Q., Ren, X., Song, X., Xu, H., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109040 · Cited by 46
Antidiabetic drugs and kidney disease
Zanchi, A., Lehmann, R., & Philippé, J. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13629 · Cited by 44
Tian, Y., Qiu, Z., Wang, F., Deng, S., Wang, Y., Wang, Z., Yin, P., Huo, Y., Zhou, M., Liu, G., et al. (2024) · Diabetes Care · doi:10.2337/dca24-0012 · Cited by 46
Batelaan, N. M., ten Have, M., van Balkom, A. J. L. M., Tuithof, M., & de Graaf, R. (2014) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2013.12.003 · Cited by 43
Glycemic Exposure, Glycemic Control, and Metabolic Karma in Diabetic Complications
Thomas, M. C. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.03.004 · Cited by 45
Serum glucose and risk of cancer: a meta-analysis
Crawley, D., Holmberg, L., Melvin, J. C., Loda, M. F., Chowdhury, S., Rudman, S. M., & Hemelrijck, M. V. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-985 · Cited by 44
Chen, L., Chubak, J., Boudreau, D. M., Barlow, W. E., Weiss, N. S., & Li, C. I. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0687 · Cited by 43
Social Determinants of Poor Management of Type 2 Diabetes Among the Insured
Patel, M. R. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01354-4 · Cited by 43
Case-finding strategies in non-alcoholic fatty liver disease
Boursier, J., & Tsochatzis, E. A. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100219 · Cited by 45
Is immunity a mechanism contributing to statin-induced diabetes?
Henriksbo, B. D., & Schertzer, J. D. (2015) · Adipocyte · doi:10.1080/21623945.2015.1024394 · Cited by 46
Omega-3 and Omega-6 Fatty Acids and Type 2 Diabetes
Jeppesen, C., Schiller, K., & Schulze, M. B. (2013) · Current Diabetes Reports · doi:10.1007/s11892-012-0362-8 · Cited by 43
Akasaka, H., Sugimoto, K., Shintani, A., Taniuchi, S., Yamamoto, K. I., Iwakura, K., Okamura, A., Takiuchi, S., Fukuda, M., Kamide, K., et al. (2022) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14363 · Cited by 41
Metadata
- Authors
- The Emerging Risk Factors Collaboration
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- The Emerging Risk Factors Collaboration
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-03-03
- Volume
- 364
- Issue
- 9
- Pages
- 829-841
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4109980
- OpenAlex
- W2126919962
- Semantic Scholar
- a89247dcde559e5839cef19b130059e2ad9abc75
- Cited by
- 2,726
- References
- 40
- Citations by year
- 2026: 102 · 2025: 138 · 2024: 186 · 2023: 151 · 2022: 200 · 2021: 225 · 2020: 218 · 2019: 182 · 2018: 190 · 2017: 203 · 2016: 190 · 2015: 196 · 2014: 193 · 2013: 145 · 2012: 147
- FWCI
- 141.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Socio-Environmental Systems Modeling (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Site cant be reached (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- OPUS (Augsburg University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- British Heart Foundation (RG/08/013/25942, RG/08/014, PG/09/002/26056, RG/07/008/23674, RG/08/014/24067)
- National Institutes of Health (n01hc085082-026, n01hc085081-021, n01hc085079-024, n01hc085083-027, n01hc085080-026, n01hc085086-022, UL1TR000062, n01hc55222-0-0-0)
- Economic and Social Research Council (ES/G007438/1)
- National Institute on Aging (R01AG023629)
- National Heart, Lung, and Blood Institute (N01 HC085086, N01 HC085079, N01 HC085083, N01 HC085080, HHSN 268200800007C, N01HC085082, U01HL080295, N01 HC055222, N01 HC085081)
- National Center for Research Resources (UL1RR025014)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, fasting blood glucose, hyperglycemia, cause-specific mortality, cancer mortality, vascular death, premature mortality, liver cancer, pancreatic cancer, ovarian cancer, colorectal cancer, lung cancer, breast cancer, renal disease mortality, infectious disease mortality, intentional self-harm, chronic obstructive pulmonary disease, mortality risk factors
- MeSH terms
- Blood Glucose, Cause of Death, Diabetes Mellitus, Female, Humans, Hyperglycemia, Life Expectancy, Male, Middle Aged, Risk, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
